Metraipolis › archive › dc_c1f4db5217c8
In Utero Molecular-Targeted Drug Therapies: Translational Principles, Pharmacologic Considerations, and Emerging Clinical Applications — Europe PMC PMID:42452421
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42452421
- DOI
- 10.3390/jcm15134960
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T02:27:24.656Z
- SHA-256 of the archived text
49f9f3cfb8ec30b09f79b5a4cd2c151dd148a253fdac0bd2a639cb058efd5d52- Stable URL of this page
https://metraipolis.com/documento/dc_c1f4db5217c8
How to cite
In Utero Molecular-Targeted Drug Therapies: Translational Principles, Pharmacologic Considerations, and Emerging Clinical Applications — Europe PMC PMID:42452421 — Europe PMC (en), https://europepmc.org/article/MED/42452421 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c1f4db5217c8 (Metraipolis archive dc_c1f4db5217c8, sha256 49f9f3cfb8ec30b09f79b5a4cd2c151dd148a253fdac0bd2a639cb058efd5d52)
BibTeX
@misc{dcc1f4db5217c8,
title = {In Utero Molecular-Targeted Drug Therapies: Translational Principles, Pharmacologic Considerations, and Emerging Clinical Applications — Europe PMC PMID:42452421},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42452421},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c1f4db5217c8; sha256 49f9f3cfb8ec30b09f79b5a4cd2c151dd148a253fdac0bd2a639cb058efd5d52},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42452421. Agents can read the archived copy with the MCP tool read_document.